Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP block versus ICNB in uniportal VATS
2021-006201-29Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Feb 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by UZ Leuven. Primary endpoint: Cumulative 12-hour morphine consumption post-surgery. Started Feb 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2021-006201-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006201-29.